KR102218224B1 - Cosmetic composition for preventing or improving skin inflammation or skin aging comprising fermented product of Ligularia stenocephala leaf as an active ingredient - Google Patents

Cosmetic composition for preventing or improving skin inflammation or skin aging comprising fermented product of Ligularia stenocephala leaf as an active ingredient Download PDF

Info

Publication number
KR102218224B1
KR102218224B1 KR1020190016253A KR20190016253A KR102218224B1 KR 102218224 B1 KR102218224 B1 KR 102218224B1 KR 1020190016253 A KR1020190016253 A KR 1020190016253A KR 20190016253 A KR20190016253 A KR 20190016253A KR 102218224 B1 KR102218224 B1 KR 102218224B1
Authority
KR
South Korea
Prior art keywords
leaf
fermentation
fermented product
cosmetic composition
active ingredient
Prior art date
Application number
KR1020190016253A
Other languages
Korean (ko)
Other versions
KR20200098799A (en
Inventor
한갑훈
이중희
오동순
김종화
강정란
Original Assignee
우석대학교 산학협력단
김원신
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 우석대학교 산학협력단, 김원신 filed Critical 우석대학교 산학협력단
Priority to KR1020190016253A priority Critical patent/KR102218224B1/en
Publication of KR20200098799A publication Critical patent/KR20200098799A/en
Application granted granted Critical
Publication of KR102218224B1 publication Critical patent/KR102218224B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 곤달비잎의 발효물을 유효성분으로 함유하는 피부염증 또는 피부노화의 예방 또는 개선용 화장료 조성물에 관한 것으로, 구체적으로 곤달비잎의 분말이 함유된 액체배지에 바실러스 서브틸리스(Bacillus subtilis), 락토바실러스 플란타럼(Lactobacillus plantarum) 및 사카로마이세스 세레비지에(Saccharomyces cerevisiae)를 접종하고 발효하여 수득한 발효물을 유효성분으로 함유하는 피부염증 또는 피부노화의 예방 또는 개선용 화장료 조성물에 관한 것이다.
본 발명의 화장료 조성물은 특정한 발효를 통해 수득된 곤달비잎의 발효물을 유효성분으로 함유함으로써, 우수한 항염증 활성 및 항산화 활성을 나타내어 피부염증 또는 피부노화의 예방 또는 개선에 우수한 효과를 나타낼 수 있다.
The present invention relates to a cosmetic composition for the prevention or improvement of skin inflammation or skin aging containing a fermented product of gondalbee leaf as an active ingredient, specifically Bacillus subtilis in a liquid medium containing the powder of gondalbee leaf , Lactobacillus plantarum (Lactobacillus plantarum) and Saccharomyces cerevisiae (Saccharomyces cerevisiae) inoculation and fermentation of the obtained fermented product containing as an active ingredient for the prevention or improvement of skin inflammation or skin aging cosmetic composition About.
The cosmetic composition of the present invention may exhibit excellent anti-inflammatory activity and antioxidant activity by containing a fermented product of gondalbee leaf obtained through a specific fermentation as an active ingredient, thereby exhibiting excellent effects in preventing or improving skin inflammation or skin aging.

Figure 112019014761586-pat00003
Figure 112019014761586-pat00003

Description

곤달비잎의 발효물을 유효성분으로 함유하는 피부염증 또는 피부노화의 예방 또는 개선용 화장료 조성물{Cosmetic composition for preventing or improving skin inflammation or skin aging comprising fermented product of Ligularia stenocephala leaf as an active ingredient}Cosmetic composition for preventing or improving skin inflammation or skin aging comprising fermented product of Ligularia stenocephala leaf as an active ingredient}

본 발명은 곤달비잎의 발효물을 유효성분으로 함유하는 피부염증 또는 피부노화의 예방 또는 개선용 화장료 조성물에 관한 것으로, 구체적으로 곤달비잎의 분말이 함유된 액체배지에 바실러스 서브틸리스(Bacillus subtilis), 락토바실러스 플란타럼(Lactobacillus plantarum) 및 사카로마이세스 세레비지에(Saccharomyces cerevisiae)를 접종하고 발효하여 수득한 발효물을 유효성분으로 함유하는 피부염증 또는 피부노화의 예방 또는 개선용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for the prevention or improvement of skin inflammation or skin aging containing a fermented product of gondalbee leaf as an active ingredient, specifically Bacillus subtilis in a liquid medium containing the powder of gondalbee leaf , Lactobacillus plantarum (Lactobacillus plantarum) and Saccharomyces cerevisiae (Saccharomyces cerevisiae) inoculation and fermentation of the obtained fermented product containing as an active ingredient for the prevention or improvement of skin inflammation or skin aging cosmetic composition About.

중국, 베이징, 인도 그리고 우리나라는 현재 미세먼지가 매우 심각한 단계에 있으며, 이런 미세먼지는 현대인 모두에게 호흡기 질환뿐만 아니라 피부질환까지 이어져 접촉성 피부염이나 습진 등 여러 형태의 피부질환을 유발하며 건강과 생활에 심각한 피해를 나타내고 있다.China, Beijing, India and Korea are currently in a very serious stage of fine dust, and these fine dusts lead to skin diseases as well as respiratory diseases for all modern people, causing various types of skin diseases such as contact dermatitis and eczema, and health and life. Is showing serious damage to

국외 및 국내 화장품 산업의 꾸준한 성장과 특히, 피부과학을 화장품에 접목한 '더마코스메틱화장품' 시장의 경우 미세먼지 등으로 인한 민감성 피부관련 트러블 진정완화 제품 시장규모는 5000억원으로 매년 15% 이상 성장하고 있다.In the case of the steadily growing overseas and domestic cosmetics industry and, in particular, in the'Derma Cosmetics' market, which combines skin science with cosmetics, the market size of soothing products for sensitive skin-related troubles caused by fine dust, etc. is 500 billion won, growing more than 15% annually. have.

발효(Fermentation)는 미생물효소를 이용하여 유기물을 분해시키는 과정을 말하며, 역사상 가장 오래된 기술인 발효법은 식품, 약품, 화장품 등 여러 분야에서 다양하게 활용되고 있고, 그 중에서도 식품발효는 우리나라뿐 아니라 전 세계적으로 가장 널리 이용되고 있다. 식품발효의 경우 가공정의 전통적인 한 방법으로 미생물의 효소작용을 통해 식품의 향, 풍미, 조직감을 향상시켜주며, 발효과정을 통해 독성물질을 파괴하고, 생리활성물질을 증진시키는 효과가 있는 것으로 알려져 있다.Fermentation refers to the process of decomposing organic matter using microbial enzymes, and the fermentation method, the oldest technology in history, is widely used in various fields such as food, medicine, and cosmetics. Among them, food fermentation is not only in Korea but also worldwide. It is the most widely used. In the case of food fermentation, it is known that it has the effect of improving the flavor, flavor, and texture of food through the enzyme action of microorganisms as a traditional method of processing refinement, destroying toxic substances through fermentation, and enhancing physiologically active substances. .

한편, 우리 산야에 자생하거나 재배되는 곤달비는 곰취와 유사한 산나물로 주로 식품의 재료로 이용되고 있으며, 아직까지 화장품 등의 뷰티용품에는 활용되지 못하고 있는 실정이다.On the other hand, gondalbi, which is grown or cultivated in Korea, is a wild vegetable similar to Gomchwi, and is mainly used as a food ingredient, and has not yet been used in beauty products such as cosmetics.

본 발명자는 이러한 곤달비를 화장품에 활용하고자 하였으며, 곤달비를 원료로 사용하여 우수한 생리활성을 갖는 발효물을 수득하기 위한 발효 방법을 개발하고 이 발효물을 화장료에 적용함으로써 우수한 기능성을 갖는 화장료 조성물을 개발하고자 하였다.The inventors of the present invention attempted to utilize this gondalbi in cosmetics, developed a fermentation method to obtain a fermented product with excellent physiological activity by using gondalbi as a raw material, and developed a cosmetic composition having excellent functionality by applying the fermented product to cosmetics I wanted to.

대한민국 등록특허 제10-1694229호Korean Patent Registration No. 10-1694229

본 발명의 주된 목적은 곤달비의 특정한 발효를 통해 수득된 발효물을 함유함으로써 피부염증 또는 피부노화의 예방 또는 개선에 우수한 효과를 나타내는 화장료 조성물을 제공하는데 있다.The main object of the present invention is to provide a cosmetic composition exhibiting an excellent effect in preventing or improving skin inflammation or skin aging by containing a fermented product obtained through specific fermentation of Gondalbi.

본 발명의 한 양태에 따르면, 본 발명은 곤달비잎의 분말이 함유된 액체배지에 바실러스 서브틸리스(Bacillus subtilis), 락토바실러스 플란타럼(Lactobacillus plantarum) 및 사카로마이세스 세레비지에(Saccharomyces cerevisiae)를 접종하고 발효하여 수득한 발효물을 유효성분으로 함유하는 피부염증 또는 피부노화의 예방 또는 개선용 화장료 조성물을 제공한다.According to one aspect of the present invention, the present invention is Bacillus subtilis (Bacillus subtilis), Lactobacillus plantarum (Lactobacillus plantarum) and Saccharomyces cerevisiae (Saccharomyces cerevisiae) in a liquid medium containing the powder of Gondal Bee leaf. ) It provides a cosmetic composition for preventing or improving skin inflammation or skin aging containing a fermented product obtained by inoculation and fermentation as an active ingredient.

본 발명의 화장료 조성물에 있어서, 상기 액체배지는 상기 곤달비잎 분말이 10 내지 30g/L로 함유되며, 당이 더 함유되는 것이 바람직하다.In the cosmetic composition of the present invention, the liquid medium contains 10 to 30 g/L of the gondalbee leaf powder, and it is preferable that sugar is further contained.

본 발명의 화장료 조성물에 있어서, 상기 발효물은 상기 액체배지에 바실러스 서브틸리스(Bacillus subtilis), 락토바실러스 플란타럼(Lactobacillus plantarum) 및 사카로마이세스 세레비지에(Saccharomyces cerevisiae)를 접종하고 30 내지 40℃에서 100 내지 200rpm으로 2 내지 4일간 진탕 발효하여 수득한 것이 바람직하다.In the cosmetic composition of the present invention, the ferment is inoculated with Bacillus subtilis , Lactobacillus plantarum and Saccharomyces cerevisiae in the liquid medium, and 30 It is preferably obtained by shaking fermentation for 2 to 4 days at 100 to 200 rpm at 40°C.

본 발명의 화장료 조성물은 특정한 발효를 통해 수득된 곤달비잎의 발효물을 유효성분으로 함유함으로써, 우수한 항염증 활성 및 항산화 활성을 나타내어 피부염증 또는 피부노화의 예방 또는 개선에 우수한 효과를 나타낼 수 있다.The cosmetic composition of the present invention may exhibit excellent anti-inflammatory activity and antioxidant activity by containing a fermented product of gondalbee leaf obtained through a specific fermentation as an active ingredient, thereby exhibiting excellent effects in preventing or improving skin inflammation or skin aging.

도 1은 본 발명의 일실시예에 따른 곤달비잎 발효물의 세포 독성 실험 결과를 나타낸 것이다. control, 대조군(무처리); 10 ~ 2.5mg/ml, 본 발명의 발효물의 농도별 처리군; 곤달비발효0d, 발효전; 곤달비발효3d, 발효 3일 후; 곤달비발효7d, 발효 7일 후.
도 2는 본 발명의 일실시예에 따른 곤달비잎 발효물의 NO 생성 억제 효과 실험 결과를 나타낸 것이다. control, 대조군(무처리); LPS10ng, LPS(10ng/㎖) 처리군; 곤달비0d1~0.25mg, 곤달비잎 발효전 혼합물의 농도별 처리군; 곤달비3d1~0.25mg, 곤달비잎을 3일 발효한 발효물의 농도별 처리군; 곤달비7d1~0.25mg, 곤달비잎을 7일 발효한 발효물의 농도별 처리군.
도 3은 본 발명의 일실시예에 따른 곤달비잎 발효물의 NO 생성 억제 효과 실험 결과를 나타낸 것이다. control, 대조군(무처리); LPS10ng/ml, LPS(10ng/㎖) 처리군; 곤달비0d1~0.25mg/ml, 곤달비잎 발효전 혼합물의 농도별 처리군; 곤달비3d1~0.25mg/ml, 곤달비잎을 3일 발효한 발효물의 농도별 처리군; 곤달비7d1~0.25mg/ml, 곤달비잎을 7일 발효한 발효물의 농도별 처리군.
도 4는 본 발명의 일실시예에 따른 곤달비잎 발효물의 총 폴리페놀 함량을 나타낸 것이다. 곤달비0d10~2.5mg/ml, 곤달비잎 발효전 혼합물의 농도별 처리군; 곤달비3d10~2.5mg/ml, 곤달비잎을 3일 발효한 발효물의 농도별 처리군; 곤달비7d10~2.5mg/ml, 곤달비잎을 7일 발효한 발효물의 농도별 처리군.
도 5는 본 발명의 일실시예에 따른 곤달비잎 발효물의 총 플라보노이드 함량을 나타낸 것이다. 곤달비0d5~1.25mg/ml, 곤달비잎 발효전 혼합물의 농도별 처리군; 곤달비3d5~1.25mg/ml, 곤달비잎을 3일 발효한 발효물의 농도별 처리군; 곤달비7d5~1.25mg/ml, 곤달비잎을 7일 발효한 발효물의 농도별 처리군.
도 6은 본 발명의 일실시예에 따른 곤달비잎 발효물의 DPPH 라디칼 소거활성을 나타낸 것이다. 10 ~ 2.5mg/ml, 본 발명의 발효물의 농도별 처리군; VC100~10ug/ml, vitamin C 농도별 처리군; 곤달비발효0d, 발효전; 곤달비발효3d, 발효 3일 후; 곤달비발효7d, 발효 7일 후.
Figure 1 shows the results of the cytotoxicity test of fermented gondalbi leaf according to an embodiment of the present invention. control, control (no treatment); 10 ~ 2.5mg / ml, treatment group by concentration of the fermented product of the present invention; Gondalbi fermentation 0d, before fermentation; Gondal fermentation 3d, 3 days after fermentation; Gondal fermentation 7d, 7 days after fermentation.
Figure 2 shows the experimental results of the NO production inhibitory effect of fermented gondalbi leaf according to an embodiment of the present invention. control, control (no treatment); LPS10ng, LPS (10ng/ml) treatment group; Gondalbi 0d1~0.25mg, treatment group by concentration of the mixture before fermentation of Gondalbi leaf; Gondalbi 3d1~0.25mg, treatment group by concentration of fermented fermented gondalbee leaves for 3 days; Gondalbi 7d1~0.25mg, treatment group of fermented products fermented with gondalbi leaves for 7 days by concentration.
Figure 3 shows the experimental results of the NO production inhibitory effect of fermented gondalbi leaf according to an embodiment of the present invention. control, control (no treatment); LPS10ng/ml, LPS(10ng/ml) treatment group; Gondalbi 0d1~0.25mg/ml, treatment group by concentration of the mixture before fermentation of Gondalbi leaf; Gondalbi 3d1~0.25mg/ml, treatment group by concentration of fermented fermented gondalbi leaves for 3 days; Gondalbi 7d1~0.25mg/ml, treatment group by concentration of fermented fermented gondalbee leaves for 7 days.
Figure 4 shows the total polyphenol content of fermented gondalbi leaf according to an embodiment of the present invention. Gondalbi 0d10~2.5mg/ml, treatment group by concentration of the mixture before fermentation of Gondalbi leaf; Gondalbi 3d10~2.5mg/ml, treatment group by concentration of fermented fermented gondalbee leaves for 3 days; Gondalbi 7d10~2.5mg/ml, treatment group by concentration of fermented fermented gondalbee leaves for 7 days.
Figure 5 shows the total flavonoid content of fermented gondalbi leaf according to an embodiment of the present invention. Gondalbi 0d5~1.25mg/ml, treatment group by concentration of the mixture before fermentation of Gondalbi leaf; Gondalbi 3d5~1.25mg/ml, treatment group by concentration of fermented fermented gondalbi leaves for 3 days; Gondalbi 7d5~1.25mg/ml, treatment group by concentration of fermented fermented gondalbee leaves for 7 days.
Figure 6 shows the DPPH radical scavenging activity of fermented gondalbi leaf according to an embodiment of the present invention. 10 ~ 2.5mg / ml, treatment group by concentration of the fermentation of the present invention; VC100~10ug/ml, treatment group by vitamin C concentration; Gondalbi fermentation 0d, before fermentation; Gondal fermentation 3d, 3 days after fermentation; Gondal fermentation 7d, 7 days after fermentation.

본 발명의 화장료 조성물은 곤달비잎의 분말이 함유된 액체배지에 바실러스 서브틸리스(Bacillus subtilis), 락토바실러스 플란타럼(Lactobacillus plantarum) 및 사카로마이세스 세레비지에(Saccharomyces cerevisiae)를 접종하고 발효하여 수득한 발효물을 유효성분으로 함유하는 것을 특징으로 한다.The cosmetic composition of the present invention is fermented by inoculating Bacillus subtilis , Lactobacillus plantarum , and Saccharomyces cerevisiae in a liquid medium containing the powder of Gondalbee leaf. It is characterized by containing the obtained fermented product as an active ingredient.

본 발명에서 상기 곤달비잎의 분말은 식물재료를 분말화하는 통상적인 방법을 통해 수득할 수 있으나, 곤달비의 생잎을 동결건조하여 분말화한 것을 사용하는 것이 본 발명의 효과를 높이기 위해 바람직하다.In the present invention, the powder of the gondalbi leaf can be obtained through a conventional method of pulverizing the plant material, but it is preferable to use a powder obtained by lyophilizing the green leaf of the gondalbi in order to increase the effect of the present invention.

본 발명에서 상기 액체배지는 상기 곤달비잎의 분말과 함께 발효기간 중 상기 발효균들이 생존하는데 필요한 영양소를 물에 첨가하는 방법으로 수득할 수 있다. 상기 액체배지는 상기 곤달비잎 분말이 10 ~ 30g/L로 함유되며, 추가 영양소로 당이 더 함유되는 것이 바람직하다. 이때 상기 당으로는 포도당(glucose)과 자당(sucrose)을 사용하는 것이 바람직하며, 액체배지 중 포도당 1 ~ 10g/L 및 자당 1 ~ 10g/L를 함유하는 것이 바람직하다.In the present invention, the liquid medium can be obtained by adding nutrients necessary for the fermentation bacteria to survive during the fermentation period together with the powder of the gondalbi leaf to water. The liquid medium contains 10 to 30 g/L of the gondalbee leaf powder, and it is preferable that sugar is further contained as an additional nutrient. At this time, it is preferable to use glucose and sucrose as the sugar, and it is preferable to contain 1 to 10 g/L of glucose and 1 to 10 g/L of sucrose in the liquid medium.

상기 액체배지는 발효과정에 발생할 수 있는 잡균의 증식으로 인한 잘못된 발효를 방지하기 위하여 발효균을 접종하기 전에 멸균하는 과정을 거치는 것이 바람직하다. 이때 멸균은 통상적인 액체의 멸균방법을 사용할 수 있으나, 고온고압 가열하는 방법을 사용하는 것이 바람직하다.The liquid medium is preferably sterilized before inoculation of the fermenting bacteria in order to prevent erroneous fermentation due to the growth of various bacteria that may occur during the fermentation process. At this time, the sterilization may use a conventional liquid sterilization method, but it is preferable to use a method of high temperature and high pressure heating.

본 발명에서는 발효균으로 바실러스 서브틸리스, 락토바실러스 플란타럼 및 사카로마이세스 세레비지에를 사용하는데, 이때 바실러스 서브틸리스 균주로 KCCM 11316, ATCC 6633, IFO 3134, DSM 347 또는 NRRL B-209를 사용하는 것이 바람직하며, 락토바실러스 플란타럼 균주로 KCCM 11322, ATCC 8014, IFO 3070, DSM 20205 또는 NRRL B-531를 사용하는 것이 바람직하고, 사카로마이세스 세레비지에 균주로 KCCM 11215, IFO 1833 또는 NRRL Y-12637를 사용하는 것이 바람직하다.In the present invention, Bacillus subtilis, Lactobacillus plantarum and Saccharomyces cerevisiae are used as fermenting bacteria, in which case KCCM 11316, ATCC 6633, IFO 3134, DSM 347 or NRRL B-209 are used as Bacillus subtilis strains. It is preferable to use, and it is preferable to use KCCM 11322, ATCC 8014, IFO 3070, DSM 20205 or NRRL B-531 as the Lactobacillus plantarum strain, and KCCM 11215, IFO as the Saccharomyces cerevisiae strain. It is preferred to use 1833 or NRRL Y-12637.

본 발명에서 상기 접종은 상기 발효균의 전배양액을 상기 액체배지에 첨가하는 방법으로 이루어질 수 있다. 이때 발효균의 전배양액은 발효균이 생장할 수 있는 액체배지에 발효균을 접종하여 배양하는 방법으로 수득할 수 있다. 이때 바실러스 서브틸리스의 배양은 TSB 액체배지에서 30 ~ 40℃, 100 ~ 200rpm으로 1 ~ 3일간 진탕배양하는 방법을 사용하는 것이 바람직하며, 락토바실러스 플란타럼의 배양은 MRS 액체배지에서 30 ~ 40℃, 100 ~ 200rpm으로 1 ~ 3일간 진탕배양하는 방법을 사용하는 것이 바람직하고, 사카로마이세스 세레비지에의 배양은 YEPD 액체배지에서 30 ~ 40℃, 100 ~ 200rpm으로 1 ~ 3일간 진탕배양하는 방법을 사용하는 것이 바람직하다. 이렇게 수득된 전배양액을 각 균주배양액 당 0.5 ~ 2%(v/v)로 첨가하여 접종하는 것이 발효효율을 높이기 위해 바람직하다.In the present invention, the inoculation may be performed by adding the pre-culture solution of the fermenting bacteria to the liquid medium. At this time, the pre-culture solution of the fermenting bacteria can be obtained by inoculating and culturing the fermenting bacteria in a liquid medium in which the fermenting bacteria can grow. At this time, Bacillus subtilis is preferably cultured in TSB liquid medium at 30 to 40°C and 100 to 200 rpm for 1 to 3 days, and Lactobacillus plantarum is cultured in MRS liquid medium. It is preferable to use a method of shaking culture at 40℃, 100 ~ 200rpm for 1-3 days, and culture of Saccharomyces cerevisiae is performed in YEPD liquid medium by shaking for 1-3 days at 30 ~ 40℃ and 100 ~ 200rpm It is preferable to use the method of culturing. In order to increase the fermentation efficiency, it is preferable to inoculate the pre-culture solution obtained in this way by adding 0.5 to 2% (v/v) per strain culture solution.

본 발명에서 상기 발효는 상기 발효균이 접종된 곤달비잎 분말 함유 액체배지를 발효균의 생장 및 발효가 가능한 온도에서 적절한 시간동안 유지하는 방법으로 이루어질 수 있다. 이때 온도는 30 ~ 40℃가 바람직하며, 100 ~ 200rpm으로 2 ~ 4일간 진탕 발효하는 것이 바람직하다.In the present invention, the fermentation may be performed by maintaining the liquid medium containing the gondalbee leaf powder inoculated with the fermenting bacteria at a temperature capable of growth and fermentation of the fermenting bacteria for an appropriate time. At this time, the temperature is preferably 30 ~ 40 ℃, it is desirable to ferment shaking for 2 ~ 4 days at 100 ~ 200rpm.

본 발명에서 상기와 같은 방법을 통해 제조된 발효물을 그대로 이용할 수 있으나, 고형물을 제거하고 동결건조하여 사용하는 것이 바람직하다. 이때 고형물의 제거는 통상의 고형물 침강, 여과, 원심분리 등의 방법을 사용할 수 있다.In the present invention, the fermented product prepared through the above method can be used as it is, but it is preferable to use it after removing the solid material and lyophilizing it. At this time, the solids may be removed by conventional methods such as sedimentation, filtration, and centrifugation.

본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 형태, 예를 들어 스킨, 로션, 크림, 에센스, 영양수, 화장수, 팩, 비누, 샴푸, 린스, 클렌징, 전신 세정제, 세안제, 트리트먼트 및 미용액의 형태로 제조될 수 있으며, 이들 형태의 화장료를 제조하는 과정 중에 상기 발효물을 첨가하는 방법으로 제조할 수 있다. 이때 발효물의 첨가량은 화장료의 종류, 형태, 목적, 제조방법 등을 고려하여 적절하게 선택될 수 있으며, 예를 들어 전체 화장료 조성물의 중량을 기준으로 상기 발효물을 0.1 ~ 20중량%로 함유할 수 있다.The cosmetic composition of the present invention is a form commonly prepared in the art, for example, skin, lotion, cream, essence, nutrient water, lotion, pack, soap, shampoo, rinse, cleansing, body cleanser, face wash, treatment and essence It may be prepared in the form of, and may be prepared by adding the fermented product during the manufacturing process of these types of cosmetics. At this time, the amount of fermented product added may be appropriately selected in consideration of the type, shape, purpose, and manufacturing method of the cosmetic, and for example, the fermented product may contain 0.1 to 20% by weight based on the weight of the total cosmetic composition. have.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하기로 한다. 이들 실시예는 단지 본 발명을 예시하기 위한 것이므로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는다.Hereinafter, the present invention will be described in more detail through examples. Since these examples are for illustrative purposes only, the scope of the present invention is not to be construed as being limited by these examples.

[실시예][Example]

1. 곤달비잎 발효물 제조1. Manufacture of fermented gondalbee leaf

1-1. 발효미생물 준비1-1. Preparation of fermentation microorganisms

바실러스 서브틸리스(Bacillus subtilis)(KCCM 11316), 락토바실러스 플란타럼(Lactobacillus plantarum)(KCCM 11322) 및 사카로마이세스 세레비지에(Saccharomyces cerevisiae)(KCCM 11215)를 각각 TSA, MRS, YEPD 고체배지에 평판도말하고 36℃에서 2일간 배양한 다음 각 배양된 균주 1백금이를 100㎖의 TSB, PDB, YEPD 액체배지에 접종하여 36℃에서 2일간 160rpm으로 진탕배양하였다. Bacillus subtilis (KCCM 11316), Lactobacillus plantarum (KCCM 11322) and Saccharomyces cerevisiae (KCCM 11215) were TSA, MRS, YEPD solids, respectively. Plates were plated on the medium and cultured at 36° C. for 2 days, and then each cultured strain 1 platinum was inoculated into 100 ml of TSB, PDB, and YEPD liquid medium, followed by shaking culture at 36° C. for 2 days at 160 rpm.

1-2. 발효물 제조1-2. Fermentation production

액체배지Liquid medium per literper liter 성 분 명Last name 함량content glucoseglucose 5g5g sucrosesucrose 5g5g 곤달비 생잎 동결건조 분말Raw Gondalbee Leaf Freeze-Dried Powder 20g20g 증류수Distilled water up to 1000㎖up to 1000ml

표 1과 같이 액체배지를 준비하고 121℃, 1.5psi로 30분간 멸균하고 식힌 다음 상기 1-1의 각 균주배양액을 10㎖ 씩 첨가하여 접종하고, 36℃에서 160rpm으로 0 ~ 7일간 진탕발효하였다.As shown in Table 1, a liquid medium was prepared, sterilized at 121°C for 30 minutes at 1.5psi, cooled, and 10 ml of each strain culture solution of 1-1 was added and inoculated, followed by shaking fermentation at 36°C at 160 rpm for 0 to 7 days. .

이후, 발효액을 4℃에서 24시간 저온 침강한 다음 4℃, 4,500rpm으로 원심분리하여 상등액을 수득하고, 각각 5㎛ 및 0.45㎛ pore size의 필터로 2회 여과한 다음 여과액을 동결건조하였다.Thereafter, the fermentation broth was settled at 4° C. for 24 hours at low temperature, and then centrifuged at 4° C. and 4,500 rpm to obtain a supernatant, and filtered twice with a filter having a pore size of 5 μm and 0.45 μm, respectively, and the filtrate was freeze-dried.

2. 세포 독성 실험2. Cytotoxicity test

상기 실시예 1의 발효물(동결건조 분말) 시료의 세포 독성을 조사하였다.The cytotoxicity of the fermented product (lyophilized powder) sample of Example 1 was investigated.

2-1. 세포배양2-1. Cell culture

실험에 사용한 RAW264.7(TIB-71; ATCC, USA) 대식세포는 American type cell collection(ATCC, USA)으로부터 구입하였으며, 사용한 배지는 DMEM(Dulbecco's Modified Eagle's Medium; Gibco, USA) 배지에 10% FBS(Fetal Bovine Serum; Gibco, USA)와 1%의 Penicillin(100U/㎖)/Streptocycin(100㎍/㎖)/Amphotericin B (0.25㎍/㎖)를 첨가한 후, 37℃, 5% CO2 조건하에서 배양하여 사용하였다.RAW264.7 (TIB-71; ATCC, USA) macrophages used in the experiment were purchased from American type cell collection (ATCC, USA), and the medium used was 10% FBS in DMEM (Dulbecco's Modified Eagle's Medium; Gibco, USA) medium. (Fetal Bovine Serum; Gibco, USA) and 1% of Penicillin (100U/ml)/Streptocycin (100µg/ml)/Amphotericin B (0.25µg/ml) were added, and then under the conditions of 37°C and 5% CO 2 It was used after culturing.

2-2. 세포 독성 평가(MTT assay) 세포생존율(Cell Viability Assay)2-2. Cytotoxicity assessment (MTT assay) Cell Viability Assay

시료에 대한 세포 생존율을 EZ-Cytox(Enhanced Cell Viability Assay kit, DoGenBio Co.,Ltd.) 방법으로 측정하였다. 세포는 5×104 cell/well 의 농도로 96-well plate에 분주하고 24시간 배양 후 배지를 제거하였다. 여기에 새로운 DMEM(10% FBS, 1% Penicillin(100U/㎖)/Streptocycin(100㎍/㎖)/Amphotricin B(0.25㎍/㎖)) 180㎕에 농도별로 희석한 시료를 각각 20㎕ 첨가하여 24시간 배양한 다음 EZ-Cytox 시약 10㎕를 각 well에 첨가하고 1시간 동안 37℃, 5% CO2 조건하에서 배양하였다. 1시간 동안 반응한 후 ELISA reader를 이용하여 450nm에서 흡광도를 측정하였다.The cell viability of the sample was measured by the EZ-Cytox (Enhanced Cell Viability Assay kit, DoGenBio Co., Ltd.) method. The cells were dispensed into a 96-well plate at a concentration of 5×10 4 cells/well and cultured for 24 hours, and then the medium was removed. Add 20 µl of each sample diluted by concentration to 180 µl of new DMEM (10% FBS, 1% Penicillin (100U/ml)/Streptocycin (100µg/ml)/Amphotricin B (0.25µg/ml)). After incubation for time, 10 µl of EZ-Cytox reagent was added to each well and incubated for 1 hour at 37° C. and 5% CO 2 . After reacting for 1 hour, the absorbance was measured at 450 nm using an ELISA reader.

2-3. 결과2-3. result

실험결과 도 1과 같이, 실시예 1의 발효물은 모든 농도에서 대조군과 비교하여 큰 세포독성은 없는 것으로 나타났다.Experimental results As shown in Fig. 1, the fermented product of Example 1 was found to have no significant cytotoxicity compared to the control at all concentrations.

3. NO 생성 억제 효과3. NO production inhibitory effect

상기 실시예 1의 발효물(동결건조 분말) 시료의 NO 생성 억제 효과를 조사하였다. NO 생성 억제 효과는 항염증 효과의 지표로 사용된다.The effect of inhibiting NO generation of the fermented product (lyophilized powder) sample of Example 1 was investigated. The NO production inhibitory effect is used as an indicator of the anti-inflammatory effect.

RAW 264.7 세포를 2.5×105 cell/㎖의 농도로 12-well plate에 분주한 다음 24시간 배양한 후 배지를 제거하였다. 여기에 새로운 DMEM(10% FBS, 1% Penicillin (100U/㎖)/Streptocycin(100㎍/㎖)Amphotericin B(0.25㎍/㎖))배지에 1㎎/㎖로 희석한 시료를 1시간 동안 전처리한 뒤 LPS(10ng/㎖)를 처리하여 24시간 동안 37℃, 5% CO2 조건하에서 배양하였다. 시료처리 24시간 후에 세포배양액 원심분리한 후 상등액 100㎕와 Griess 시약 A액(1% sulfanilamide) 50㎕ + B액(0.1% N-(1-naphtyl)ethylenediamine dihydrochloride) 50㎕를 혼합하여 96 well plates에서 20분 동안 반응시킨 후 ELISA reader를 이용하여 540nm에서 흡광도를 측정하였다. 결과는 1M NaNO2로 Standard curve를 작성하여 세포배양 상등액에 함유되어 있는 NO의 값을 계산하였다.RAW 264.7 cells were dispensed into a 12-well plate at a concentration of 2.5×10 5 cells/ml, cultured for 24 hours, and then the medium was removed. Here, a sample diluted to 1 mg/ml in fresh DMEM (10% FBS, 1% Penicillin (100U/ml)/Streptocycin (100µg/ml) Amphotericin B (0.25µg/ml)) medium was pretreated for 1 hour. Then, LPS (10 ng/ml) was treated and incubated for 24 hours at 37°C and 5% CO 2 . After 24 hours of sample treatment, the cell culture solution was centrifuged, and 100 µl of the supernatant and 50 µl of Griess reagent A (1% sulfanilamide) + 50 µl of B solution (0.1% N-(1-naphtyl) ethylenediamine dihydrochloride) were mixed to 96 well plates. After reacting at for 20 minutes, the absorbance was measured at 540 nm using an ELISA reader. As a result , a standard curve was drawn with 1M NaNO 2, and the value of NO contained in the cell culture supernatant was calculated.

이의 결과 도 2 및 3과 같이, 실시예 1의 발효물 모두 우수한 NO 생성 억제 효과가 있는 것으로 나타났으며, 특히 3일 발효한 경우 NO 생성 억제 효과가 가장 우수한 것으로 나타났다.As a result of this, as shown in FIGS. 2 and 3, both of the fermented products of Example 1 were found to have an excellent inhibitory effect on NO generation, and particularly, when fermented for 3 days, the effect of inhibiting NO generation was the most excellent.

4. 총 폴리페놀 함량4. Total polyphenol content

상기 실시예 1의 발효물(동결건조 분말) 시료의 총 폴리페놀 함량을 조사하였다.The total polyphenol content of the fermented product (lyophilized powder) sample of Example 1 was investigated.

총 폴리페놀 함량은 Na Hyun Lee et al.(2015)의 방법을 이용하여 측정하였다. 시료용액(10 ~ 2.5㎎/㎖의 농도로 물로 희석) 또는 Gallic acid standard(0, 20, 40, 60, 80, 100㎎/L) 100㎕에 2% Na2CO3 용액 2㎖를 가하고 충분히 교반한 다음 3분 방치한 후 50% Folin & Ciocalteu's phenol reagents 100㎕를 가하여 Vortexing한 후 암실에서 30분간 반응 시킨 후 750nm에서 blank를 대조로 하여 흡광도를 측정하였다. 페놀성 화합물을 정량하기 위해 gallic acid를 표준물질로 하여 구한 검량선으로부터 계산하였다.The total polyphenol content was measured using the method of Na Hyun Lee et al. (2015). Add 2 ml of 2% Na 2 CO 3 solution to 100 μl of sample solution (diluted with water to a concentration of 10 ~ 2.5 mg/ml) or Gallic acid standard (0, 20, 40, 60, 80, 100 mg/L) After stirring and allowing to stand for 3 minutes, 50% Folin &Ciocalteu's phenol reagents 100 µl were added and vortexed, reacted in a dark room for 30 minutes, and the absorbance was measured using a blank at 750 nm as a control. To quantify the phenolic compound, it was calculated from a calibration curve obtained using gallic acid as a standard material.

이의 결과 도 4와 같이, 실시예 1의 발효물 모두 총 폴리페놀 함량이 높은 것으로 나타났다.As a result of this, as shown in FIG. 4, it was found that all of the fermented products of Example 1 had a high total polyphenol content.

5. 총 플라보노이드 함량5. Total flavonoid content

상기 실시예 1의 발효물(동결건조 분말) 시료의 총 플라보노이드 함량을 조사하였다.The total flavonoid content of the fermented product (lyophilized powder) sample of Example 1 was investigated.

총 플라보노이드 함량은 Hongmei Geng.(2008)의 방법을 변형하여 측정하였다. 시료용액(5 ~ 1.25㎎/㎖의 농도로 물로 희석) 또는 Rutin hydrate standard(0, 10, 20, 30, 40, 50㎎/L) 2㎖와 5% NaNO2 0.3㎖를 혼합한 후 실온에서 6분간 반응시킨 다음 10% Al(NO3)3 0.3㎖를 가하여 실온에서 6분간 반응한 후에 10% NaOH 용액 4㎖를 가하여 충분히 교반한 다음 2차 증류수로 10㎖를 채워서 혼합하여 15분간 반응시킨 다음 분광 광도계(OPTIZEN POP 메카시스)를 이용하여 510nm에서 blank를 대조로 하고 각 용액의 흡광도를 측정하였다. 총 플라보노이드 함량은 Rutin hydrate를 표준물질로 하여 작성한 검량선으로부터 계산하였다.The total flavonoid content was measured by modifying the method of Hongmei Geng. (2008). After mixing 2 ml of sample solution (diluted with water to a concentration of 5 to 1.25 mg/ml) or Rutin hydrate standard (0, 10, 20, 30, 40, 50 mg/L) and 0.3 ml of 5% NaNO 2, After reacting for 6 minutes, 0.3 ml of 10% Al(NO 3 ) 3 was added and reacted for 6 minutes at room temperature. After 4 ml of 10% NaOH solution was added and stirred sufficiently, 10 ml of 2 distilled water was added to the mixture, followed by reaction for 15 minutes. Then, using a spectrophotometer (OPTIZEN POP Meccasys), the blank was compared at 510 nm and the absorbance of each solution was measured. The total flavonoid content was calculated from a calibration curve prepared using Rutin hydrate as a standard material.

이의 결과 도 5와 같이, 실시예 1의 발효물 모두 총 플라보노이드 함량이 높은 것으로 나타났다.As a result of this, as shown in FIG. 5, it was found that all of the fermented products of Example 1 had a high total flavonoid content.

6. 항산화 효과6. Antioxidant effect

상기 실시예 1의 발효물(동결건조 분말) 시료의 농도별(10㎎/㎖, 5㎎/㎖, 2.5㎎/㎖, 1.25㎎/㎖) 항산화 효과를 조사하였다.The antioxidant effect of the fermented product (lyophilized powder) sample of Example 1 by concentration (10 mg/ml, 5 mg/ml, 2.5 mg/ml, 1.25 mg/ml) was investigated.

DPPH 라디칼 소거활성 시험방법으로 항산화 효과를 조사하였으며, Seon-hee you(2016)의 방법에서 변형한 DPPH 라디칼 소거활성 시험방법을 사용하였다. 0.1mM DPPH(2,2-diphenyl-1-picrylhydrazyl) 용액을 96-well plate에 180㎕ 씩 동량 첨가한 후 2차 증류수에 녹인 여러 농도의 시료를 20㎕ 씩 가하여 37℃에서 30분간 반응 시킨 후 517nm에서 흡광도를 측정하였다. 이때 대조군으로는 Ascorbic acid(비타민 C)를 사용하였다. DPPH 라디칼 소거활성은 아래의 식으로 산출하였다.The antioxidant effect was investigated by the DPPH radical scavenging activity test method, and the DPPH radical scavenging activity test method modified from the method of Seon-hee you (2016) was used. 0.1mM DPPH (2,2-diphenyl-1-picrylhydrazyl) solution was added to a 96-well plate in an equal amount of 180 µl each, and then 20 µl of samples of various concentrations dissolved in distilled water were added each to react at 37°C for 30 minutes. Absorbance was measured at 517 nm. At this time, ascorbic acid (vitamin C) was used as a control. DPPH radical scavenging activity was calculated by the following equation.

DPPH 라디칼 소거활성(%) = 100 - {(첨가군 흡광도 / 무첨가군 흡광도) × 100}DPPH radical scavenging activity (%) = 100-{(absorbance in added group / absorbance in no added group) × 100}

이의 결과 도 6과 같이, 실시예 1의 발효물 모두 우수한 항산화 활성을 나타내었다.As a result, as shown in FIG. 6, both fermented products of Example 1 exhibited excellent antioxidant activity.

Claims (3)

곤달비 생잎 동결건조 분말 10 내지 30g/L, 포도당 1 내지 10g/L 및 자당 1 내지 10g/L를 함유하는 액체배지에 바실러스 서브틸리스(Bacillus subtilis), 락토바실러스 플란타럼(Lactobacillus plantarum) 및 사카로마이세스 세레비지에(Saccharomyces cerevisiae)를 접종하고 30 내지 40℃에서 100 내지 200rpm으로 2 내지 4일간 진탕 발효하여 수득한 발효물을 유효성분으로 함유하는 피부염증 또는 피부노화의 예방 또는 개선용 화장료 조성물.
Bacillus subtilis (Bacillus subtilis), Lactobacillus plantarum (Lactobacillus plantarum) and saccharin in a liquid medium containing 10 to 30 g/L of fresh gondal leaf freeze-dried powder, 1 to 10 g/L of glucose and 1 to 10 g/L of sucrose Cosmetics for preventing or improving skin inflammation or skin aging containing fermented products obtained by inoculating Saccharomyces cerevisiae and shaking fermentation at 30 to 40°C at 100 to 200 rpm for 2 to 4 days as an active ingredient Composition.
삭제delete 삭제delete
KR1020190016253A 2019-02-12 2019-02-12 Cosmetic composition for preventing or improving skin inflammation or skin aging comprising fermented product of Ligularia stenocephala leaf as an active ingredient KR102218224B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190016253A KR102218224B1 (en) 2019-02-12 2019-02-12 Cosmetic composition for preventing or improving skin inflammation or skin aging comprising fermented product of Ligularia stenocephala leaf as an active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190016253A KR102218224B1 (en) 2019-02-12 2019-02-12 Cosmetic composition for preventing or improving skin inflammation or skin aging comprising fermented product of Ligularia stenocephala leaf as an active ingredient

Publications (2)

Publication Number Publication Date
KR20200098799A KR20200098799A (en) 2020-08-21
KR102218224B1 true KR102218224B1 (en) 2021-02-25

Family

ID=72235893

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190016253A KR102218224B1 (en) 2019-02-12 2019-02-12 Cosmetic composition for preventing or improving skin inflammation or skin aging comprising fermented product of Ligularia stenocephala leaf as an active ingredient

Country Status (1)

Country Link
KR (1) KR102218224B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220019156A (en) 2020-08-06 2022-02-16 삼성전자주식회사 Security device including physical unclonable function cells and operation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101470888B1 (en) 2013-12-24 2014-12-15 재단법인춘천바이오산업진흥원 Composition for liver protection containing the fermented extract of Ligularia fischeri

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101229748B1 (en) * 2010-02-01 2013-02-05 코스맥스 주식회사 Cosmetic compositions containing fermented extract of Hippophae rhamnoides L
KR101694229B1 (en) 2014-12-24 2017-01-10 우석대학교 산학협력단 Cosmetic composition comprising sacha inchi oil and extract of Portulaca oleracea L.
KR101878772B1 (en) * 2016-01-12 2018-07-23 우석대학교 산학협력단 Fermented beverage with Chrysanthemum zawadskii leaves

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101470888B1 (en) 2013-12-24 2014-12-15 재단법인춘천바이오산업진흥원 Composition for liver protection containing the fermented extract of Ligularia fischeri

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
노언주, 박사학위논문, 한양대학교 대학원, "곤달비의 피부 항노화 효능에 관한 연구"(2009.08.31.) 1부.*

Also Published As

Publication number Publication date
KR20200098799A (en) 2020-08-21

Similar Documents

Publication Publication Date Title
KR101370386B1 (en) Preparation method of fermented red ginseng using effective micro-organisms
KR101388918B1 (en) Lactobacillus rhamnosus HK-9 derived from human body, and fermented material and cosmetic composition using it
KR102047459B1 (en) Lactobacillus plantarum WiKim0088
US20080293669A1 (en) Composition Containing Beta-Glucan, Method of Producing the Same and Foods, Drinks or Skin Moisturizers Containing the Composition
JP2012092100A (en) Skin-whitening cosmetic composition containing green tea extract
CN109843263B (en) Cosmetic composition containing ginseng fruit fermentation product fermented by using black yeast and lactic acid bacteria
CN113604395B (en) Lactobacillus plantarum capable of fermenting dendrobium nobile and improving skin quality by fermentation liquor thereof
KR101875001B1 (en) Lactobacillus fermentum GFCSJ and cacao nibs Fermented extract Manufactured Using Thereof
KR102125316B1 (en) cosmetic composition for anti-irritation and skin soothing using Lactobacillus pentosus J2K-185strain
KR101343410B1 (en) Novel Lactobacillus plantarum CRNB-22 (KCTC 11931 BP) strain capable of fermenting ginseng and method of transforming saponin using thereof
TWI689585B (en) Novel lactic acid strain and immune activating agent containing novel lactic acid strain
KR101686112B1 (en) Composition of culture medium for cultivation of Lactobacillus, ginseng berry-fermented extracts comprising thereof and cosmetic composition for improving skin conditions
KR101194226B1 (en) Cosmetic composition for antioxidant and whitening effects having fermented paprika extract and manufacturing method thereof
KR102232341B1 (en) Cosmetic composition for preventing or improving skin aging or skin inflammation comprising fermented product of Mentha piperascens leaf and ginger as an active ingredient
KR102218224B1 (en) Cosmetic composition for preventing or improving skin inflammation or skin aging comprising fermented product of Ligularia stenocephala leaf as an active ingredient
KR20160126591A (en) Method of producing ginseng fermented extract, Ginseng fermented extract produced by the same and Health functional foods comprising the same
KR102097509B1 (en) Novel lactic acid bacteria and method of preparing fermented product having effect of anti-obesity and anti-diabets using the same
KR101713176B1 (en) Fermented medicinal-herb composition having antioxidation activity and and method for preparing thereof
KR20220039942A (en) Saccharomyces cerevisiae FT4-4 strain having antioxidant activity and tyrosinase inhibitory activity isolated from blueberry and uses thereof
KR20220103315A (en) Cosmetic composition for Anti-oxidative or Anti-inflammatory comprising the Fermented extract Stems and Leaf of Watermelon
KR20000060083A (en) Fermented product using lactic acid bacteria and cosmetic composition
KR101263567B1 (en) Preparation Method of Fermented Medicinal-Herb Composition And Fermented Medicinal-Herb Composition Using The Same
KR101768817B1 (en) Food composition for anti-oxidation and inhanced immunity comprising chamomile flower extract short-term fermented by lactic acid bacteria and the method of preparation thereof
KR20160131585A (en) Extracts of fermented-allium hookeri using lactic acid bacteria and method thereof
KR20200000743A (en) A composition for improving diabetes or for use of antioxidant comprising yeast extract and a method for preparing the yeast extract

Legal Events

Date Code Title Description
N231 Notification of change of applicant
E701 Decision to grant or registration of patent right